13F HOLDINGS REPORT
Avidity Partners Management LP
Quarter ended Q4 2023 · Filed November 14, 2023 · Accession 0001791827-23-000006
Total Value
$2.48B
Positions
83
Other Managers
0
Confidential Omitted
No
Holdings (83)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | BOSTON SCIENTIFIC CORP | BSX | 2,065,800 | $109.1M | 4.39% |
| 2 | JAZZ PHARMACEUTICALS PLC | JAZZ | 797,500 | $103.2M | 4.16% |
| 3 | BECTON DICKINSON & CO | BDX | 286,800 | $74.1M | 2.99% |
| 4 | NEUROCRINE BIOSCIENCES INC | NBIX | 652,100 | $73.4M | 2.95% |
| 5 | MCKESSON CORP | MCK | 166,300 | $72.3M | 2.91% |
| 6 | LEGEND BIOTECH CORP | LEGN | 967,000 | $65.0M | 2.62% |
| 7 | TENET HEALTHCARE CORP | THC | 963,800 | $63.5M | 2.56% |
| 8 | THE CIGNA GROUP | 125523100 | 207,700 | $59.4M | 2.39% |
| 9 | IDEAYA BIOSCIENCES INC | IDYA | 2,144,971 | $57.9M | 2.33% |
| 10 | UNITEDHEALTH GROUP INC | UNH | 112,200 | $56.6M | 2.28% |
| 11 | SAREPTA THERAPEUTICS INC | SRPT | 450,000 | $54.5M | 2.20% |
| 12 | HUMANA INC | HUM | 110,300 | $53.7M | 2.16% |
| 13 | ARVINAS INC | ARVN | 2,614,960 | $51.4M | 2.07% |
| 14 | ACADIA HEALTHCARE COMPANY IN | ACHC | 715,000 | $50.3M | 2.02% |
| 15 | KARUNA THERAPEUTICS INC | 48576A100 | 286,700 | $48.5M | 1.95% |
| 16 | REGENERON PHARMACEUTICALS | REGN | 58,000 | $47.7M | 1.92% |
| 17 | ZOETIS INC | ZTS | 262,100 | $45.6M | 1.84% |
| 18 | IMMUNOVANT INC | IMVT | 1,173,662 | $45.1M | 1.81% |
| 19 | MOONLAKE IMMUNOTHERAPEUTICS | MLTX | 777,172 | $44.3M | 1.78% |
| 20 | DANAHER CORPORATION | 235851102 | 176,600 | $43.8M | 1.76% |
| 21 | ZENTALIS PHARMACEUTICALS INC | ZNTL | 2,100,000 | $42.1M | 1.70% |
| 22 | INTRA-CELLULAR THERAPIES INC | 46116X101 | 801,100 | $41.7M | 1.68% |
| 23 | SYNDAX PHARMACEUTICALS INC | SNDX | 2,821,000 | $41.0M | 1.65% |
| 24 | ELI LILLY & CO | LLY | 75,000 | $40.3M | 1.62% |
| 25 | NATERA INC | NTRA | 899,000 | $39.8M | 1.60% |
| 26 | ARGENX SE | ARGX | 80,600 | $39.6M | 1.60% |
| 27 | SURGERY PARTNERS INC | SGRY | 1,338,000 | $39.1M | 1.58% |
| 28 | LANTHEUS HLDGS INC | LNTH | 558,400 | $38.8M | 1.56% |
| 29 | VAXCYTE INC | PCVX | 756,165 | $38.5M | 1.55% |
| 30 | BLUEPRINT MEDICINES CORP | 09627Y109 | 751,600 | $37.7M | 1.52% |
| 31 | AKERO THERAPEUTICS INC | 00973Y108 | 739,100 | $37.4M | 1.51% |
| 32 | MIRUM PHARMACEUTICALS INC | MIRM | 1,142,850 | $36.1M | 1.45% |
| 33 | PRIVIA HEALTH GROUP INC | PRVA | 1,545,100 | $35.5M | 1.43% |
| 34 | DEXCOM INC | DXCM | 377,700 | $35.2M | 1.42% |
| 35 | BIOHAVEN LTD | BHVN | 1,285,400 | $33.4M | 1.35% |
| 36 | ROCKET PHARMACEUTICALS INC | RCKTW | 1,587,429 | $32.5M | 1.31% |
| 37 | AMYLYX PHARMACEUTICALS INC | AMLX | 1,756,940 | $32.2M | 1.30% |
| 38 | IMMUNOGEN INC | 45253H101 | 1,917,907 | $30.4M | 1.23% |
| 39 | BIOGEN INC | BIIB | 115,400 | $29.7M | 1.19% |
| 40 | CARIBOU BIOSCIENCES INC | CRBU | 6,050,212 | $28.9M | 1.16% |
| 41 | ARROWHEAD PHARMACEUTICALS IN | ARWR | 1,063,897 | $28.6M | 1.15% |
| 42 | HCA HEALTHCARE INC | HCA | 114,800 | $28.2M | 1.14% |
| 43 | NEUMORA THERAPEUTICS INC. | NMRA | 1,800,000 | $25.4M | 1.02% |
| 44 | STRUCTURE THERAPEUTICS INC | GPCR | 500,000 | $25.2M | 1.02% |
| 45 | UNIVERSAL HLTH SVCS INC | 913903100 | 182,000 | $22.9M | 0.92% |
| 46 | CUREVAC N V | N2451R105 | 3,116,100 | $21.3M | 0.86% |
| 47 | AXSOME THERAPEUTICS INC | AXSM | 296,800 | $20.7M | 0.84% |
| 48 | ULTRAGENYX PHARMACEUTICAL IN | RARE | 544,000 | $19.4M | 0.78% |
| 49 | PROTHENA CORP PLC | PRTA | 382,305 | $18.4M | 0.74% |
| 50 | REVOLUTION MEDICINES INC | RVMDW | 657,200 | $18.2M | 0.73% |
| 51 | CRINETICS PHARMACEUTICALS IN | CRNX | 610,000 | $18.1M | 0.73% |
| 52 | IMMUNOCORE HLDGS PLC | IMCR | 348,200 | $18.1M | 0.73% |
| 53 | ROIVANT SCIENCES LTD | ROIV | 1,503,302 | $17.6M | 0.71% |
| 54 | AN2 THERAPEUTICS INC | ANTX | 1,089,400 | $17.5M | 0.71% |
| 55 | PHATHOM PHARMACEUTICALS INC | PHAT | 1,617,300 | $16.8M | 0.68% |
| 56 | DIANTHUS THERAPEUTICS INC | DNTH | 1,217,554 | $16.6M | 0.67% |
| 57 | FUSION PHARMACEUTICALS INC | 36118A100 | 5,781,850 | $15.0M | 0.61% |
| 58 | CEREVEL THERAPEUTICS HLDNG I | 15678U128 | 643,000 | $14.0M | 0.57% |
| 59 | VERONA PHARMA PLC | 925050106 | 830,300 | $13.5M | 0.55% |
| 60 | VENTYX BIOSCIENCES INC | 92332V107 | 354,900 | $12.3M | 0.50% |
| 61 | INTELLIA THERAPEUTICS INC | NTLA | 379,100 | $12.0M | 0.48% |
| 62 | TRAVERE THERAPEUTICS INC | TVTX | 1,323,000 | $11.8M | 0.48% |
| 63 | SCHRODINGER INC | SDGR | 399,000 | $11.3M | 0.45% |
| 64 | KARYOPHARM THERAPEUTICS INC | KPTI | 8,298,570 | $11.1M | 0.45% |
| 65 | RAYZEBIO INC | 75525N107 | 500,000 | $11.1M | 0.45% |
| 66 | XENON PHARMACEUTICALS INC | XENE | 321,400 | $11.0M | 0.44% |
| 67 | PACIFIC BIOSCIENCES CALIF IN | 69404D108 | 1,034,294 | $8.6M | 0.35% |
| 68 | AC IMMUNE SA | ACIU | 2,969,800 | $8.5M | 0.34% |
| 69 | COLLEGIUM PHARMACEUTICAL INC | COLL | 350,200 | $7.8M | 0.32% |
| 70 | ALPINE IMMUNE SCIENCES INC | 02083G100 | 657,280 | $7.5M | 0.30% |
| 71 | KEZAR LIFE SCIENCES INC | KZR | 6,011,100 | $7.2M | 0.29% |
| 72 | SYROS PHARMACEUTICALS INC | 87184Q206 | 1,581,142 | $6.2M | 0.25% |
| 73 | GRITSTONE BIO INC | 39868T105 | 2,733,800 | $4.7M | 0.19% |
| 74 | ALPHATEC HLDGS INC | ATEC | 309,400 | $4.0M | 0.16% |
| 75 | NANOSTRING TECHNOLOGIES INC | 63009R109 | 2,299,100 | $4.0M | 0.16% |
| 76 | VERVE THERAPEUTICS INC | 92539P101 | 285,334 | $3.8M | 0.15% |
| 77 | COMPASS THERAPEUTICS INC | CMPX | 1,599,600 | $3.2M | 0.13% |
| 78 | ALTIMMUNE INC | ALT | 1,159,900 | $3.0M | 0.12% |
| 79 | SCYNEXIS INC | SCYX | 1,319,444 | $3.0M | 0.12% |
| 80 | HYPERFINE INC | HYPR | 1,188,178 | $2.4M | 0.10% |
| 81 | CENTURY THERAPEUTICS INC | IPSC | 1,098,500 | $2.2M | 0.09% |
| 82 | CAREMAX INC | 14171W103 | 636,000 | $1.3M | 0.05% |
| 83 | NUVATION BIO INC | NUVB | 89,543 | $8,954 | 0.00% |